[The pharmacokinetics of recombinant human erythropoietin].
Siniukhin
V N
VN
Stetsiuk
E A
EA
Lovchinskiĭ
E V
EV
Lebedev
S V
SV
Iarmolinskiĭ
I S
IS
Liakhov
V V
VV
D000740:Anemia / Q000188:drug therapy / Q000209:etiology / Q000378:metabolism; D003131:Combined Modality Therapy; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D006801:Humans; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D006435:Renal Dialysis / Q000009:adverse effects; D013997:Time Factors
D011994:Recombinant Proteins; D004921:Erythropoietin
Farmakokinetika rekombinantnogo chelovecheskogo éritropoétina.